Company Overview

PRIME exits® and American Healthcare Capital are excited to exclusively represent an established and highly successful neurology and sleep clinic located in the southwestern United States. Established in 2010, it is a premier provider of outpatient clinical services for patients with neurological and sleep disorders. The clinic also provides support to patients with central and peripheral neurological damage resulting from personal injuries.

A single provider leads the clinic with a staff of ten FTEs, including one nurse practitioner. In addition, the clinic retains the services of three independent contractors who perform transcranial doppler, electroencephalogram (EEG), and neurophysiology testing.

The clinic operates in a leased facility comprising 2,500 sq ft with five patient rooms, including one sleep lab.

Practice and Payer Mix

The patient mix is 45% neurology, 30% sleep disorders, and 25% injury related. The payer mix is 15% Medicaid, 25% Medicare, 25% commercial insurance, 5% cash, and 30% from personal injury cases. The current patient volume is approximately 40 per day, resulting in around 8,000 visits per year. The clinic is open four days per week.

The clinic performs a range of neurologic procedures using in-house equipment, including home sleep testing, EEG, EMG/NGV testing, VNG testing, and transcranial Doppler. It also provides Botox therapy for migraine, nerve blocks, vagus nerve stimulation, and Inspire device monitoring.

Growth Opportunity

There is a substantial opportunity for growth by adding additional neurologists at the facility, opening additional facilities in the region, and expanding therapeutic options in the personal injury sector.

Reason For Selling

The owner is nearing retirement age and would like to transfer the business aspects of the clinic to focus solely on patient care. The owner intends to stay with the business for a few years, helping it grow and transitioning patient care in an appropriate manner.

Financial Overview

The clinic has seen a rise in topline income over the past two years. Income increased from $1.89 million in 2022 to $2.06 million in 2024, representing steady top-line momentum. The first half of 2025 reflects a significant jump in revenue and profitability, with the clinic on track to achieve nearly $2.4 million in 2025 and an adjusted EBITDA of approximately $1.24 million (45%). The revenue growth is being driven by personal injury care, accounting for 30% of patient flow and 50% of revenue.

Asking Price

The price is to be determined. The owner will consider an acquisition with an earnout tied to performance in the first full year after the acquisition.